Wird geladen...
Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
Multiple categories of medications have been developed to manage lipid profiles and reduce the risk of cardiovascular events in patients with heart disease. However, currently marketed medications have not solved the problems associated with preventing and treating cardiovascular diseases completely...
Gespeichert in:
| Veröffentlicht in: | Vasc Health Risk Manag |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844254/ https://ncbi.nlm.nih.gov/pubmed/27143910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82387 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|